DrugPatentWatch Database Preview
VABOMERE Drug Profile
Which patents cover Vabomere, and what generic alternatives are available?
Vabomere is a drug marketed by Rempex Pharms and is included in one NDA. There are two patents protecting this drug.
This drug has eighteen patent family members in fourteen countries.
The generic ingredient in VABOMERE is meropenem; vaborbactam. There are thirty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the meropenem; vaborbactam profile page.
Summary for VABOMERE
| International Patents: | 18 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VABOMERE |
| DailyMed Link: | VABOMERE at DailyMed |
Generic Entry Opportunity Date for VABOMERE
Generic Entry Date for VABOMERE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
POWDER;IV (INFUSION) |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for VABOMERE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rempex Pharms | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Rempex Pharms | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for VABOMERE
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Mexico | 2013001517 | ➤ Try a Free Trial |
| China | 103180328 | ➤ Try a Free Trial |
| Japan | 2013535502 | ➤ Try a Free Trial |
| South Korea | 20130099923 | ➤ Try a Free Trial |
| New Zealand | 607354 | ➤ Try a Free Trial |
| Japan | 6266978 | ➤ Try a Free Trial |
| Russian Federation | 2599791 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
